Ursula Matulonis, M.D.

Ursula Matulonis Explains the Use of PARP Inhibitors for Ovarian Cancer

March 13, 2017

Video

Ursula Matulonis, M.D., professor of Medicine, Harvard Medical School, Medical Director of Gynecologic Oncology, Dana-Farber Cancer Institute, explains the benefits of PARP inhibitors for patients with ovarian cancer.